Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

MTX2Mandibuloacral Dysplasia

Autosomal recessive mandibuloacral dysplasia (MAD) due to biallelic MTX2 variants is a recently described skeletal dysplasia characterized by postnatal growth retardation (HP:0008897), hypotonia (HP:0001252) and generalized lipodystrophy (HP:0009064). A single unrelated 6-year-old patient presenting with these features underwent whole-exome sequencing, which identified a novel homozygous c.543+1G>T splice site variant in MTX2 ([PMID:36269149]). Patient RNA analysis by RT-PCR and Sanger sequencing confirmed exon 8 skipping, consistent with loss-of-function. No additional affected family members or segregation data are available. On the basis of one proband with molecular splicing confirmation and absence of replication, the gene–disease association is classified as Limited. Diagnostic MTX2 testing informs clinical surveillance and genetic counseling for affected families.

References

  • American journal of medical genetics. Part A • 2023 • A novel MTX2 gene splice site variant resulting in exon skipping, causing the recently described mandibuloacral dysplasia progeroid syndrome. PMID:36269149

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

One unrelated proband with biallelic MTX2 splice variant and molecular splicing confirmation; no additional families or segregation data

Genetic Evidence

Limited

Biallelic null MTX2 variant identified in a single case of MAD; no further segregation (PMID:36269149)

Functional Evidence

Moderate

Patient RNA analysis confirmed exon 8 skipping for c.543+1G>T, consistent with loss-of-function (PMID:36269149)